このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
China Medical System Holdings マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Kong Lam
最高経営責任者
CN¥5.4m
報酬総額
CEO給与比率 | 93.5% |
CEO在任期間 | 17.5yrs |
CEOの所有権 | 47.5% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 12yrs |
経営陣の近況
Recent updates
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
May 03We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package
May 02China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 19China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
Mar 29Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%
Mar 28China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up
Dec 21Is China Medical System Holdings (HKG:867) A Risky Investment?
Dec 04If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Nov 15China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342
Aug 31China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Aug 30Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today
Aug 07We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease
May 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 26An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued
Feb 05China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly
Dec 26If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Dec 08Is China Medical System Holdings (HKG:867) Using Too Much Debt?
Sep 14China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year
Aug 25Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?
Aug 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued
Jul 08Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
May 16Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Apr 10China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28
Mar 22If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late
Feb 09Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Dec 25Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
Nov 10China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Sep 25China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32
Aug 26Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching
Jul 30An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued
Jun 27China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Jun 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 20Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?
Mar 25Shareholders Are Loving China Medical System Holdings Limited's (HKG:867) 3.0% Yield
Mar 08CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Dec 31 2023 | CN¥5m | CN¥5m | CN¥2b |
Sep 30 2023 | n/a | n/a | CN¥3b |
Jun 30 2023 | n/a | n/a | CN¥3b |
Mar 31 2023 | n/a | n/a | CN¥3b |
Dec 31 2022 | CN¥6m | CN¥5m | CN¥3b |
Sep 30 2022 | n/a | n/a | CN¥3b |
Jun 30 2022 | n/a | n/a | CN¥3b |
Mar 31 2022 | n/a | n/a | CN¥3b |
Dec 31 2021 | CN¥5m | CN¥4m | CN¥3b |
Sep 30 2021 | n/a | n/a | CN¥3b |
Jun 30 2021 | n/a | n/a | CN¥3b |
Mar 31 2021 | n/a | n/a | CN¥3b |
Dec 31 2020 | CN¥4m | CN¥4m | CN¥3b |
Sep 30 2020 | n/a | n/a | CN¥2b |
Jun 30 2020 | n/a | n/a | CN¥2b |
Mar 31 2020 | n/a | n/a | CN¥2b |
Dec 31 2019 | CN¥4m | CN¥3m | CN¥2b |
Sep 30 2019 | n/a | n/a | CN¥2b |
Jun 30 2019 | n/a | n/a | CN¥2b |
Mar 31 2019 | n/a | n/a | CN¥2b |
Dec 31 2018 | CN¥3m | CN¥3m | CN¥2b |
Sep 30 2018 | n/a | n/a | CN¥2b |
Jun 30 2018 | n/a | n/a | CN¥2b |
Mar 31 2018 | n/a | n/a | CN¥2b |
Dec 31 2017 | CN¥782k | CN¥610k | CN¥2b |
報酬と市場: Kongの 総報酬 ($USD 750.68K ) は、 Hong Kong市場 ($USD 501.01K ) の同規模の企業の平均を上回っています。
報酬と収益: Kongの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Kong Lam (59 yo)
17.5yrs
在職期間
CN¥5,443,000
報酬
Dr. Lam Kong founded and serves as the Chairman and Chief Executive Officer of China Medical System Holdings Limited and has been its Executive Director since December 18, 2006. Mr. Lam serves as President...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 17.5yrs | CN¥5.44m | 47.45% CN¥ 7.7b | |
CFO, VP & Executive Director | 17.5yrs | CN¥4.43m | 0.30% CN¥ 48.0m | |
COO, VP | 17.5yrs | CN¥5.04m | 2.88% CN¥ 465.1m | |
Independent Non-Executive Director | 6.5yrs | CN¥323.00k | データなし | |
Independent Non-Executive Director | 4.3yrs | CN¥323.00k | データなし | |
Independent Non-Executive Director | 2.7yrs | CN¥323.00k | データなし |
12.0yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: 867の 取締役会 は経験豊富で 経験豊富 です ( 12年の平均在任期間)。